A shadow market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Investigational Drug Acquiring Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these profiles privately for supplier links, while also obtaining discount codes.
Thriving Commerce on Social Networks
Additionally, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors market the substance there before redirecting customers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Professionals Voice Concerns
However, physicians and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users injecting substances of unknown origin.
Some professionals said the popularity for retatrutide could be connected to the rising cost of licensed slimming products such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach medicines, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.
Service Response and Content Removal
According to the social media company, the platform has taken down problematic material and prohibited associated keywords and search suggestions. The organization said it was dedicated to maintaining the service secure and investing in strengthening compliance measures.
Digital Marketplace Activities
Research also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of users, populated with photos of slimming results, glowing reviews and step-by-step guides for preparing or injecting at home.
Within minutes of joining one community, a vendor posted contact information, where most transactions occur. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, health issues or previous experience.
Product Information and Costs
Within these communities, messages show black plastic parcels with Royal Mail labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how long a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A representative for the messaging service stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.
Her team has already seen patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company investigational product not yet authorized … may subject users to possibly serious health risks”.
